SCHEMBL10306808

SCHEMBL10306808

C[C@H](CCC=O)NC(=O)c1ccc(CCc2c[nH]c3nc(N)nc(O)c23)cc1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ TYMS P04818 7/20 0.56
▸ DHFR P00374 6/20 0.56
▸ FOLR2 P14207 1/20 0.47
▸ FOLR1 P15328 1/20 0.47
▸ GART P22102 1/20 0.47
▸ ATIC P31939 1/20 0.47
▸ SHMT1 P34896 1/20 0.47
▸ SLC19A1 P41440 1/20 0.47
▸ FRK P42685 1/20 0.47
▸ SLC46A1 Q96NT5 1/20 0.47
▸ NAMPT P43490 1/20 0.47
▸ KMT2A Q03164 3/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ HTT P42858 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ HPGD P15428 1/20 0.40
▸ HSP90AA1 P07900 1/20 0.39
▸ LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10306795 0.91 TYMS (0.58) TYMSDHFRFOLR2FOLR1GART
SCHEMBL10306802 0.90 DHFR (0.54) TYMSDHFRFOLR2FOLR1GART
SCHEMBL10306749 0.84 DHFR (0.56) TYMSDHFRFOLR2FOLR1GART
SCHEMBL2610602 0.84 TYMS (0.67) TYMSDHFRFOLR2FOLR1GART
Pemetrexed SCHEMBL7848273 0.80 DHFR (0.83) TYMSDHFRFOLR2FOLR1GART
Pemetrexed SCHEMBL12022769 0.80 DHFR (0.83) TYMSDHFRFOLR2FOLR1GART
SCHEMBL9046718 0.80 TYMS (0.54) TYMSDHFRFOLR2FOLR1GART
SCHEMBL14329882 0.79 DHFR (0.63) TYMSDHFRFOLR2FOLR1GART
SCHEMBL15247798 0.79 NAMPT (0.52) TYMSDHFRFOLR2FOLR1GART
SCHEMBL14331358 0.79 DHFR (0.72) TYMSDHFRFOLR2FOLR1GART

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120172595-A1 NOVEL PROCESS FOR THE SYNTHESIS OF PEMETREXED DISODIUM SALT CHEMI S.P.A. (IT) 2012-07-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120172595-A1 NOVEL PROCESS FOR THE SYNTHESIS OF PEMETREXED DISODIUM SALT PCNA, POLH, TYMP TYMS 6/4885DHFR 51/4885FOLR2 129/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback